Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Mind Medicine Mindmed Inc
(NQ:
MNMD
)
5.970
-0.340 (-5.39%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Sep 20, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Mind Medicine Mindmed Inc
< Previous
1
2
3
4
5
Next >
World’s Richest Man Says Psychedelics Could Make a Real Difference in Mental Health
June 15, 2022
FN Media Group Presents Microsmallcap.com Market Commentary New York, NY – June 15, 2022 – Elon Musk believes that psychedelics and other plant-based drugs are better than pharma meds in treating a...
Via
FinancialNewsMedia
Oregon to Become the First State to Legally Roll Out Psilocybin
April 28, 2022
FN Media Group Presents Microsmallcap.com Market Commentary New York, NY – April 28, 2022 – Oregon is set to become the first US state to market legal psilocybin, the psychoactive substance found in...
Via
FinancialNewsMedia
Topics
Derivatives
ETFs
Exposures
Derivatives
Why MindMed’s LSD Trial for Anxiety May Be Important to Psychedelic Investors
April 21, 2022
Via
Investor Brand Network
Why Psychedelics Could Soon Replace Antidepressants
April 13, 2022
FN Media Group Presents Microsmallcap.com Market Commentary New York, NY – April 13, 2022 – Anxiety disorders are the most common mental illness in the US, affecting approximately 40 million adults...
Via
FinancialNewsMedia
Demand for Toad Venom Rises Along With the Booming Psychedelics Market
March 30, 2022
FN Media Group Presents Microsmallcap.com Market Commentary New York, NY – March 30, 2022 – Depression and anxiety affect millions around the world and the venom of a toad is the latest psychedelic...
Via
FinancialNewsMedia
NetworkNewsAudio – Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) Differentiates Itself in Psychedelics Space
March 07, 2022
Via
Investor Brand Network
Psychedelic Therapies Offer Hope for Mental Health
March 02, 2022
Via
Investor Brand Network
Psychedelic Therapies Offer Hope for Mental Health
March 02, 2022
Via
Investor Brand Network
Psychedelic Therapies Offer Hope for Mental Health
March 02, 2022
NetworkNewsWire Editorial Coverage New York, NY – March 2, 2022 – Neural plasticity is instrumental in brain health, and the importance of neuroplasticity can’t be overstated. Indeed, the inability of...
Via
FinancialNewsMedia
Psilocybin and MDMA Get the Green Light for Medical Use in Canada
January 19, 2022
FN Media Group Presents Microsmallcap.com Market Commentary New York, NY – January 19, 2022 – After facing legal scrutiny for decades, psychedelics including MDMA and psilocybin received a stamp of...
Via
FinancialNewsMedia
A Recap of How Psychedelics Fared in 2021
January 07, 2022
Via
Investor Brand Network
Mind Medicine (NASDAQ: MNMD) (NEO: MMED) to Study Effect of Time on LSD Microdosing
December 17, 2021
Via
Investor Brand Network
Mind Medicine Inc. (NASDAQ: MNMD) (NEO: MMED) to Conduct Study Investigating Effect of Time on LSD Microdosing
December 16, 2021
Via
Investor Brand Network
BioMedNewsBreaks – Mind Medicine (‘MindMed’) Inc. (NASDAQ: MNMD) (NEO: MMED) (DE: MMQ) Engages with FDA for Development of the ‘MSMS’
December 10, 2021
Via
Investor Brand Network
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Product Safety
North American Psychedelic Drugs Market Expected To Reach A Value Of $3.184 Billion In 2026
December 14, 2021
Palm Beach, FL –December 14, 2021 – FinancialNewsMedia.com News Commentary – The prevalence of mental health disorders has risen exponentially, and the development of novel medications has not kept...
Via
FinancialNewsMedia
This Could Be The Next Multi-Billion AI Breakthrough
November 05, 2021
FN Media Group Presents GlobalInvestmentDaily.com Market Commentary London – November 5, 2021 – There’s a massive announcement set to take place later this year, and it could change the $12 trillion...
Via
FinancialNewsMedia
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Psychedelics Offer Hope for Mental Disorders, Addiction
November 03, 2021
Via
Investor Brand Network
Intranasal Ketamine Garnering A lot of Attention as an Effective Treatment For Depression
November 23, 2021
Palm Beach, FL –November 23, 2021 – FinancialNewsMedia.com News Commentary – The COVID-19 pandemic is expected to have a significant positive impact on the growth of the global antidepressant market....
Via
FinancialNewsMedia
Exposures
COVID-19
Two Trillion-Dollar Industries Being Transformed By Tech
October 20, 2021
FN Media Group Presents Oilprice.com Market Commentary London – October 20, 2021 – Big money is pouring into two disruptive segments in two of the world’s biggest industries – healthcare and energy....
Via
FinancialNewsMedia
NetworkNewsAudio – Tryp Therapeutics Inc. (CSE: TRYP) (OTCQB: TRYPF) Bringing Therapeutic Options to Diseases with Unmet Needs
September 30, 2021
Via
Investor Brand Network
Topics
Cannabis
Exposures
Cannabis
Developments with Ketamine Psychotherapy Are Driving A Medical Revolution For Treating Mental Health Issues
October 28, 2021
Palm Beach, FL –October 28, 2021 – FinancialNewsMedia.com News Commentary – Psychedelic drugs such as psilocybin, LSD and MDMA have tremendous medical and commercial future potential… and for ketamine,...
Via
FinancialNewsMedia
Topics
Death
Law Enforcement
Exposures
Death
Legal
Psychedelics Renaissance Underway as Paradigm Shifting Cure for Depression Potentially Discovered
September 28, 2021
Via
FinancialNewsMedia
Topics
Law Enforcement
Exposures
Legal
North America Continues Leading The Way In Psychedelic Wellness
October 26, 2021
Palm Beach, FL –October 26, 2021 – FinancialNewsMedia.com News Commentary – The global psychedelic drugs market remains at an early stage in its life cycle, with most companies currently developing...
Via
FinancialNewsMedia
Investors Turning to Psychedelic Market as Renaissance Continues into New Wave of Diseases
September 27, 2021
Via
Investor Brand Network
Topics
Cannabis
Exposures
Cannabis
Rising Acceptance For Treating Mental Disorders is Fueling Strong Growth in Psychedelic Drugs Market
October 14, 2021
Palm Beach, FL –October 14, 2021 – FinancialNewsMedia.com News Commentary – Mental disorders are an urgent health crisis worldwide, especially exacerbated by COVID-19. As per a study by Harvard, the...
Via
FinancialNewsMedia
Exposures
COVID-19
Senate Bill Decriminalizing Psychedelics Could Help Reverse Some “War on Drugs” Impacts
September 22, 2021
Via
FinancialNewsMedia
U.S. Is Dominating Psychedelic Drugs Market Due To Growing Acceptance For Treating Depression & Rise In Product Approvals
October 12, 2021
Palm Beach, FL –October 12, 2021 – FinancialNewsMedia.com News Commentary – After being relegated to the margins of sincere scientific examination for about the last several decades, growing...
Via
FinancialNewsMedia
National Suicide Prevention Week Shines Light on Psychedelic Treatments
September 09, 2021
Via
FinancialNewsMedia
Psychedelics Gain More Traction as New Research Aims to Address Chronic Pain and Mental Illness
July 21, 2021
Via
FinancialNewsMedia
Topics
Law Enforcement
Exposures
Legal
Psychedelic Decriminalization Creating Market Opportunities
July 12, 2021
Via
FinancialNewsMedia
Topics
Cannabis
Law Enforcement
Exposures
Cannabis
Legal
< Previous
1
2
3
4
5
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.